Stay updated on Seladelpar in PBC & Hepatic Impairment Clinical Trial
Sign up to get notified when there's something new on the Seladelpar in PBC & Hepatic Impairment Clinical Trial page.

Latest updates to the Seladelpar in PBC & Hepatic Impairment Clinical Trial page
- ChecktodayNo Change Detected
- Check8 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe page has been updated to include new information about the drug Seladelpar, specifically its dosage and a new revision number, while significant details regarding the study's inclusion and exclusion criteria have been removed.SummaryDifference28%
- Check29 days agoChange DetectedThe web page has updated its version from v2.14.3 to v2.14.4, and the date has changed from March 25, 2025, to March 17, 2025.SummaryDifference0.3%
- Check51 days agoChange DetectedThe webpage has updated its date references, removing outdated dates and adding new ones, while also eliminating specific contact information for a clinical study.SummaryDifference3%
- Check73 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference2%
- Check87 days agoChange DetectedThe web page now includes a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference2%
Stay in the know with updates to Seladelpar in PBC & Hepatic Impairment Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Seladelpar in PBC & Hepatic Impairment Clinical Trial page.